# Spectrum Pharmaceuticals, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/spectrum-pharmaceuticals-inc/d2be8240-3764-497f-8d0d-fbedb45f3053

> Inspection records and compliance data for Spectrum Pharmaceuticals, Inc. in Boston, Massachusetts. Access full analysis and detailed observations.

---

## Details

- Name: Spectrum Pharmaceuticals, Inc.
- FEI Number: 3005383580
- City: Boston
- State: Massachusetts
- Country Name: United States
- Address Line 1: 2 Atlantic Ave Fl 6
- Zip Code: 02110

## Related Documents

- [CRL - Spectrum Pharmaceuticals, Inc. - Unknown Date](https://www.keypedia.com/records/crl/spectrum-pharmaceuticals-inc/3e23b8cc-3896-4261-8692-d70bdc16a4a4) — source: FDA, date: Invalid Date
- [FDA Inspection 1165963 - Spectrum Pharmaceuticals, Inc. - 2022-03-04](https://www.keypedia.com/records/fda_inspections/spectrum-pharmaceuticals-inc/eda95d2e-8f21-45a3-b878-8e194e9439e2) — classification: No Action Indicated (NAI), source: FDA, date: March 4, 2022
- [483 - Spectrum Pharmaceuticals, Inc. - 2020-02-12](https://www.keypedia.com/records/483/spectrum-pharmaceuticals-inc/3ae6deb6-ea4b-41f4-9fe6-c56a8fb1ece1) — source: FDA, date: February 12, 2020
- [FDA Inspection 1117779 - Spectrum Pharmaceuticals, Inc. - 2020-02-12](https://www.keypedia.com/records/fda_inspections/spectrum-pharmaceuticals-inc/fdef18b8-7dd0-44fc-abef-2f0a1fa7279d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 12, 2020
- [FDA Inspection 1006382 - Spectrum Pharmaceuticals, Inc. - 2017-03-15](https://www.keypedia.com/records/fda_inspections/spectrum-pharmaceuticals-inc/73052981-d8ac-416b-a141-b2a4fb4769f7) — classification: No Action Indicated (NAI), source: FDA, date: March 15, 2017
- [483 - Spectrum Pharmaceuticals, Inc. - 2016-05-27](https://www.keypedia.com/records/483/spectrum-pharmaceuticals-inc/f1b02020-a69a-4ae1-a502-d4bd9cca549b) — source: FDA, date: May 27, 2016
- [FDA Inspection 973856 - Spectrum Pharmaceuticals, Inc. - 2016-05-27](https://www.keypedia.com/records/fda_inspections/spectrum-pharmaceuticals-inc/c4bfdb12-55a3-41bd-b948-d1b51cf25a73) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 27, 2016
- [FDA Inspection 924451 - Spectrum Pharmaceuticals, Inc. - 2015-03-31](https://www.keypedia.com/records/fda_inspections/spectrum-pharmaceuticals-inc/e268a4f2-b436-473f-b7d7-e936f95d2348) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 31, 2015
- [FDA Inspection 924451 - Spectrum Pharmaceuticals, Inc. - 2015-03-31](https://www.keypedia.com/records/fda_inspections/spectrum-pharmaceuticals-inc/22da3cb7-315a-4736-8e21-fb71b54db200) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 31, 2015
- [FDA Inspection 870378 - Spectrum Pharmaceuticals, Inc. - 2014-03-18](https://www.keypedia.com/records/fda_inspections/spectrum-pharmaceuticals-inc/f68ce5ab-010a-480e-b46e-9d8ecd644971) — classification: No Action Indicated (NAI), source: FDA, date: March 18, 2014
- [FDA Inspection 778451 - Spectrum Pharmaceuticals, Inc. - 2012-02-02](https://www.keypedia.com/records/fda_inspections/spectrum-pharmaceuticals-inc/16f04779-d65f-4977-9ab0-b731b37102b4) — classification: No Action Indicated (NAI), source: FDA, date: February 2, 2012
- [FDA Inspection 778451 - Spectrum Pharmaceuticals, Inc. - 2012-02-02](https://www.keypedia.com/records/fda_inspections/spectrum-pharmaceuticals-inc/501ab0fb-6ff8-4479-b775-67450d3b02ec) — classification: No Action Indicated (NAI), source: FDA, date: February 2, 2012

## Related Companies

- [Pharbil Waltrop Gmbh](https://www.keypedia.com/companies/pharbil-waltrop-gmbh/f3455dea-04cf-4c53-ab8b-3fcddc45fb4c)
- [Columbia Cosmetics Manufacturing, Inc.](https://www.keypedia.com/companies/columbia-cosmetics-manufacturing-inc/c6e32c25-080a-4901-8391-8716d6517687)
- [G S Cosmeceutical USA Inc](https://www.keypedia.com/companies/g-s-cosmeceutical-usa-inc/02e5e566-9934-4417-9659-f041ee537843)
- [Buckeye International Inc](https://www.keypedia.com/companies/buckeye-international-inc/01799cae-da24-4d86-9a28-d25a72c9bc8b)
- [Evi Labs](https://www.keypedia.com/companies/evi-labs/0713d12b-117d-4b0b-a25e-2df2a5682fc4)
- [Marksans Pharma Limited](https://www.keypedia.com/companies/marksans-pharma-limited/0855d225-2181-468a-a51c-c479608c1c92)
- [McKenna Labs Inc](https://www.keypedia.com/companies/mckenna-labs-inc/a0956f9d-e7ea-4bf6-ac78-77140586f684)
- [Hillyard GMP](https://www.keypedia.com/companies/hillyard-gmp/68d27919-f3ad-48da-a664-cf48fee3133a)
- [Bell Pharmaceuticals, Inc](https://www.keypedia.com/companies/bell-pharmaceuticals-inc/bb92f552-7a5a-4a84-b282-4310321b816b)
- [PNEO, LLC](https://www.keypedia.com/companies/pneo-llc/24376518-9de6-438b-8b89-54329c09ae01)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/diane-c-van-leeuwen/98af0d70-2db1-4132-8193-fcccf8841960)
- [Lavender M Huskey](https://www.keypedia.com/people/lavender-m-huskey/9ad3f3d7-4f25-492a-b10a-ede8289e4797)
- [investigator](https://www.keypedia.com/people/angela-shepas/743113c1-799b-44e9-9422-8049c476bfd2)
- [Anil K. Hiteshi, RAC](https://www.keypedia.com/people/anil-k-hiteshi-rac/6b62587e-f762-419f-8dfd-02e8c815f30a)